RecruitingNCT05698992

Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer

Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer - a Clinical Trial Evaluating and Implementing a Model for Evidence-based Cancer Rehabilitation

Sponsor

Region Skane

Enrollment

100 participants

Start Date

Feb 27, 2023

Study Type

OBSERVATIONAL

Conditions

Esophageal Cancer Gastric Cancer Esophageal Neoplasms Stomach Neoplasm

Summary

This study aims to develop and evaluate a model for systematic and evidence-based cancer rehabilitation for people with esophageal and gastric cancer to provide conditions for a better quality of life and fewer cancer-related symptoms.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study follows patients with esophageal or stomach cancer in southern Sweden who are scheduled for curative surgery, tracking their rehabilitation and recovery journey before and after the operation to understand how to better support patients through this challenging process. **You may be eligible if...** - You are over 18 with esophageal or gastric (stomach) cancer - You live in the Skåne region of southern Sweden - You are scheduled for surgery with the intent to cure at Skåne University Hospital **You may NOT be eligible if...** - You cannot communicate in Swedish - You have a cognitive impairment that would prevent you from participating Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERevidence-based individualized rehabilitation

The experimental group will receive structured individualized assessment based on physical, psychological or social needs and will be offered evidence-based interventions to promote rehabilitation and recovery.

Locations(1)

Skåne University Hospital

Lund, Lund, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05698992

Related Trials

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT065031461 location

High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients

NCT073075603 locations

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

NCT045579691 location

DESTINY-PANTUMOUR04

NCT0712400017 locations

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

NCT0646994450 locations